Skip to main content
Premium Trial:

Request an Annual Quote

NoAb BioDiscoveries

Premium
NoAb BioDiscoveries this week launched DTEx, a microarray-based technology that profiles the effects of drugs on the gene expression of key proteins involved in drug metabolism.
 
DTEx analyzes the effects of drugs on the induction or suppression of transporter genes that play a critical role in determining the pharmacodynamic and pharmacokinetic properties of administered drugs. “This information will help scientists understand potential drug-drug interactions and to select candidates for clinical development with greater efficacy and fewer side effects,” NoAb said. The company has filed patent applications for the DTEx technology.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.